Screener
Vera Therapeutics VERA Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Vera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Vera Therapeutics’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:33 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212143
FAQ
- What is Vera Therapeutics's shares (diluted)?
- Vera Therapeutics (VERA) reported shares (diluted) of 71.5M in Q1 2026.
- How has Vera Therapeutics's shares (diluted) changed year-over-year?
- Vera Therapeutics's shares (diluted) increased by 12.3% year-over-year, from 63.7M to 71.5M.
- What is the long-term trend for Vera Therapeutics's shares (diluted)?
- Over 4 years (2021 to 2025), Vera Therapeutics's shares (diluted) has grown at a 53.9% compound annual growth rate (CAGR), from 45.6M to 255.5M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Vera Therapeutics's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude